Data regarding risk factors and long-term outcomes of U.S. patients with biopsy-proven metabolic dysfunction-associated steatotic liver disease (MASLD) are limited. This study aimed to investigate the ...
Liver cancer screening uses ultrasound and AFP biomarker tests, with CT or MRI for further evaluation if abnormalities are ...
Data regarding risk factors and long-term outcomes of U.S. patients with biopsy-proven metabolic dysfunction-associated steatotic liver disease (MASLD) are limited. This study aimed to investigate the ...
Fatty liver disease, medically called metabolic dysfunction-associated steatotic liver disease (MASLD), affects millions globally. Around one in four adults worldwide has this hidden condition. Many ...
In today’s Health Headlines, October is Liver Awareness Month – how a biopsy helps diagnose liver diseases, why fatty liver ...
Sportschosun on MSN
Hepatitis B Patients' Liver Cancer Prediction, Development of a New Model...82% accuracy
A new model has been developed that can more accurately predict the risk of liver cancer in hepatitis B patients. A research ...
Cirrhosis is the result of long-term liver injury where healthy tissue is replaced with scar tissue (fibrosis). Common causes of cirrhosis include alcohol use disorder (AUD), nonalcoholic fatty liver ...
Noninvasive liver fibrosis scores are associated with increased heart failure risk, with FIB-4, NFS, and APRI showing significant correlations. Higher scores correlate with increased heart failure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback